Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | GAA | P10253 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | PLAU | P00749 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.40 |
| ▸ | RORC | P51449 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL7033986 | 0.89 | KDM4E (0.60) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| Hydrochloric Acid SCHEMBL7036095 | 0.89 | KDM4E (0.60) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| Bromide SCHEMBL7030618 | 0.89 | KDM4E (0.60) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| Fluoride SCHEMBL7034780 | 0.89 | KDM4E (0.60) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| Sulfuric Acid SCHEMBL7032682 | 0.87 | KDM4E (0.55) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| Nitrous Acid SCHEMBL7032245 | 0.87 | KDM4E (0.55) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| SCHEMBL8742702 | 0.85 | KDM4E (0.70) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| SCHEMBL2552495 | 0.75 | KDM4E (0.55) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| SCHEMBL28140458 | 0.74 | KDM4E (0.72) | KDM4EGAASMN1; SMN2MEN1MAPT | |
| SCHEMBL13779427 | 0.74 | KDM4E (0.62) | KDM4EGAASMN1; SMN2MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030163000-A1 | Halogen exchange reactions and catalysts therefor | CHORDIP LTD. (GB) | 2003-08-28 | — | — | US | disclosed |
| EP-1288196-A1 | Process for the preparation of organo guanidinium salts | Chordip Ltd. (GB) | 2003-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030163000-A1 | Halogen exchange reactions and catalysts therefor | WEE2, WEE1, SLC39A11 | KDM4E 949/4885GAA 1629/4885SMN1; SMN2 4073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.